Showing results (451-460 of 533) with videos related to

Sort By:
Pageof 54
Nature Medicine|January 22, 2019
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's diseaseOliver Preische, Stephanie A Schultz, Anja Apel, et al.
Brain Communications|September 21, 2020
Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer's diseaseLisa Vermunt, Ellen Dicks, Guoqiao Wang, et al.
Annals of Neurology|March 27, 2016
White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer networkSeonjoo Lee, Fawad Viqar, Molly E Zimmerman, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Prediction of future cognitive decline among cognitively unimpaired individuals using measures of soluble phosphorylated tau or tau tangle pathologyRik Ossenkoppele, Gemma Salvadó, Shorena Janelidze, et al.
Nature Aging|March 29, 2025
Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trialsRik Ossenkoppele, Gemma Salvadó, Shorena Janelidze, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 13, 2018
Utility of perfusion PET measures to assess neuronal injury in Alzheimer's diseaseNelly Joseph-Mathurin, Yi Su, Tyler M Blazey, et al.
The Journal of Prevention of Alzheimer'S Disease|December 1, 2025
Towards an AI biomedical scientist: Accelerating discoveries in neurodegenerative diseaseKaleigh F Roberts, Eric C Landsness, Justin Reese, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 25, 2021
The global Alzheimer's Association round robin study on plasma amyloid β methodsJosef Pannee, Leslie M Shaw, Magdalena Korecka, et al.
Brain : a Journal of Neurology|February 13, 2019
Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkersBrian A Gordon, Tyler M Blazey, Jon Christensen, et al.
Brain Connectivity|January 12, 2021
Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer DiseaseRobert X Smith, Jeremy F Strain, Aaron Tanenbaum, et al.
Pageof 54